Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dbi-001 (4 trials)
dbi-002 (3 trials)
dbi-102 (1 trial)
hydroquinone (1 trial)
Janthinobacterium lividum (2 trials)
sm-020 (3 trials)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Tinea (Phase 2)
Tinea Pedis (Phase 2)
Trials (11 total)
Trial APIs (6 total)